Where does Raytrx, LLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Raytrx, LLC ranks #9,856 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Raytrx, LLC hold?

Raytrx, LLC holds 32 US utility patents granted between 2018 and 2025, spanning 13 technology areas.

What is Raytrx, LLC's Innovation Score?

Raytrx, LLC has an Innovation Score of 53.6 out of 100 (top 9% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Raytrx, LLC focus on?

Raytrx, LLC's top technology area is G02B (Optical Elements, Systems OR Apparatus) with 22 patents, ranking #608 of 4,891 assignees active in that subclass. Grants appear in 13 CPC subclasses total.

Is Raytrx, LLC's patent grant rate increasing or decreasing?

Raytrx, LLC's recent grant velocity is +950% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Raytrx, LLC's patents?

Raytrx, LLC's patents average 20.2 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Raytrx, LLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Raytrx, LLC

USPTO PatentsView assignee record - 32 granted patents across 13 technology areas, recorded in grant years 2018–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G02B (Optical Elements, Systems OR Apparatus).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Raytrx ranks #9,856 of 49,997 tracked US assignees by granted-patent volume, with 32 patents across 13 technology areas.

#9,856
of 49,997 US assignees by volume: Top 9%
by Innovation Score (53.6/100): 20.2
avg claims per patent: +950%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R9856 · US Corporation #9,856 · 32 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 32 grants
UPPER-Q #9,856/49,997
PHOTO-FINISH Protagonist…
CPC-FOCUS G02B · 13 areas
INNOV-PAR 53.6/100
CLAIMS-DENSE 20.2 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +950% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Protagonist Therapeutics, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Raytrx’s 53.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 12.1 pts (23%) Velocity 16.7 pts (31%) Breadth 12.7 pts (24%) Claim depth 12.1 pts (23%)

Qualcomm Incorporated · highest

85
Florida A&M University · near

54
Imasen Electric… · near

54
Raytrx · this assignee

54
AB Sandvik Coromant · near

54
Mitek Holdings · near

54
3D Lighting… · lowest

7

What this shows Raytrx's Innovation Score is 53.6/100 (top 9% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Raytrx?

Each dot is one of Raytrx’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Raytrx’s own 20.2 claims/patent is ABOVE the 12.3 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Raytrx vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Raytrx's grants concentrate

Raytrx, LLC is a focused PatentsView assignee: 13 CPC subclasses with 68.8% of grants classified under G02B (Optical Elements, Systems OR Apparatus). Peak complete grant year is 2024 (10 grants) versus a trough of 1 in 2020. By volume, Raytrx sits between Protagonist Therapeutics, Inc. and Redline Communications Inc..

Raytrx's three-year grant acceleration

Raytrx, LLC shows 15 grants in 2022–2024 against only 6 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Protagonist Thera…

32
Putco

32
Quidel

32
Rayence

32
REG Synthetic Fue…

32
Rieke Packaging S…

32
Raindance

32
Redline Communica…

32
Raytrx ◀

32

What this shows Raytrx holds 32 patents at rank #9,854, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Raytrx

By rank, the assignees closest to #9,854 in granted patent volume.

Leaders in G02B (Optical Elements)

Other assignees with the most granted patents in Raytrx's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Raytrx, neither rank-band nor same-CPC leaders (those blocks stay above). In G02B (Optical Elements), Raytrx ranks #608 of 4,891 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (54 here).

Imasen Electric Industrial Co., Ltd. 54 Florida A&M University 54 AB Sandvik Coromant 54 Mitek Holdings, Inc. 54

Raytrx's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

54 Top 9% higher than 91% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2018–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table

Raytrx, LLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2018	2	6.3%
2020	1	3.1%
2021	5	15.6%
2022	1	3.1%
2023	4	12.5%
2024	10	31.3%
2025partial year	9	28.1%

Which technologies does Raytrx, LLC patent most?

G02B - Optical Elements, Systems OR Apparatus 22

G06F - Electric Digital Data Processing 17

A61B - DIAGNOSIS; SURGERY; Identification 17

G09G - Arrangements OR Circuits FOR Control OF Indicating Devices Using Static Means TO Present Variable Information 13

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 13

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 13

H04N - Pictorial Communication, e.g. Television 12

G06T - Image Data Processing OR Generation, IN General 9

G16Z - Information AND Communication Technology [ICT] Specially Adapted FOR Specific Application Fields, NOT Otherwise Provided FOR 7

G06V - Image OR Video Recognition OR Understanding 2

G02C - SPECTACLES; Sunglasses OR Goggles Insofar AS They Have THE Same Features AS SPECTACLES; Contact Lenses 2

A42B - HATS; Head Coverings 1

F41G - Weapon SIGHTS; Aiming 1

Top 13 of 13 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Raytrx, LLC's patent record in context - here's where to go next.

Raytrx, LLC's lead technology class is G02B (Optical Elements, Systems OR Apparatus), 68.8% of its portfolio - see every assignee active in that class. Explore G02B
Ranked #9,856 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Raytrx, LLC against Protagonist Therapeutics, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 53.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.